Media OutReach
New Report Identifies 250+ Climate Adaptation and Resilience Solutions for Asia Amidst Rising Funder Interest
- Asia-focused report by the Centre for Impact Investing and Practices (CIIP) and collaborators identifies 250+ priority climate adaptation and resilience solutions for Asia,[1] based on over US$100 billion in financing flows over 5 years[2]
- Study’s survey of 165 Asian funders managing over US$1 trillion in funds finds climate adaptation and resilience emerging as top impact theme by activity and interest
- Report introduces a first-ever framework to mobilise coordinated action, mapping solutions across 3 tiers of commercial viability, highlighting entry points for commercial, philanthropic, and public capital to enable cross-sector climate adaptation action
- Accompanying fund flows dashboard provides visibility on public, private and philanthropic capital flows and funding gaps in climate adaptation and resilience across China, India, and Southeast Asia
SINGAPORE – Media OutReach Newswire – 18 May 2026 – The Centre for Impact Investing and Practices (CIIP), in partnership with Temasek, Invesco, and ImpactSF (CGIAR Hub for Sustainable Finance), and with support from Dalberg, today launched a new report on climate adaptation and resilience (CA&R) in Asia. This regional study identifies more than 250 priority climate adaptation and resilience solutions for Asia, grounded in the region’s unique climate risks, hazards, and priorities, and informed by analysis of over US$100 billion in climate adaptation and resilience financing flows between 2021 and 2025.[3]
Launching at Ecosperity Week’s Impact Investing Roundtable 2026 on 19th May, the report “Climate Adaptation and Resilience in Asia: Pricing Risk, Sizing Opportunities, Financing Solutions” examines the region’s climate risks, financing gaps, and barriers constraining investment in adaptation and resilience solutions. This includes persistent data gaps, limited visibility of investable opportunities, and unclear financing pathways.
The CA&R solutions for Asia span three tiers of commercial viability. These include 94 low or no commercial viability solutions but which are foundational in terms of building regional resilience, 93 emerging opportunities that are promising but need catalytic capital to scale, and 65 commercially viable solutions that have proven track record across markets. Together, they offer clear entry points across the spectrum of capital to support solutions at different stages of maturity — from early-stage innovation and ecosystem development to scaling proven technologies and infrastructure.
Accompanying the report are:
- A first-of-its-kind fund flow intelligence dashboard mapping public, private and philanthropic capital flows across China, India, and Southeast Asia (SEA) and impact opportunities
- The Climate Adaptation and Resilience in Asia Case Study Library featuring 50 real-world examples of companies, financial institutions and philanthropies advancing CA&R in respective ways.
- A sectoral deep dive, Building a Climate-Adapted and Resilient Agri-Food System in Southeast Asia, focused on agri-food resilience in SEA – a top priority across the region’s National Adaptation Plans
“Climate adaptation and resilience financing in Asia remains constrained by limited data, fragmented approaches, and uncertainty around where capital can be most effective. We hope this report helps to provide greater clarity on the opportunities and roles different stakeholders can play in advancing solutions across the region. As climate risks intensify, stronger coordination between public, private, and philanthropic capital will be essential to accelerate action,” said Ms. Dawn Chan, CEO, Centre for Impact Investing and Practices.
Rising climate risks, widening financing gap
As a region, Asia is warming at twice the global average. Since 2000, 3.7 billion people in Asia have been affected by climate-related disasters – more than triple that in the rest of the world. These risks are already translating into significant economic and social costs.
By 2030, Asia will account for around 75% of the global CA&R financing gap, and Asian companies are projected to bear around US$336 billion in annual climate costs.
Despite this, annual CA&R financing flows in Asia remain significantly below current funding needs. More than US$200 billion is required annually across the region, yet current flows stand at only around US$19 billion.
Agriculture is among the sectors most significantly affected by climate change. While the sector contributes 9.8% to SEA’s GDP, average annual production growth of key staple food[4] has remained below 1.3% over the past decade. Climate stress could reduce crop yields by as much as 41%, with much of the burden and impact of declining production falling on the region’s 100 million smallholder farmers, many of whom live on less than US$2 a day.
“Impacts of climate risks vary according to crop or livestock, where they are and when the risk is going to be experienced. This determines the necessary strategy required for resilience uplift. ImpactSF uses CGIAR produced scientific data along with AI-based approaches to support investment processes in risk identification and mitigation and impact reporting for investees. This is extremely critical because if risks are ignored, they will eventually impact the financial bottom line of businesses in the agriculture and food sector,” said Dr. Godefroy Grosjean, Co-Lead, CGIAR Hub for Sustainable Finance (ImpactSF).
Barriers to unlocking capital
Several structural barriers constrain capital deployment into CA&R. These include underdeveloped policy and regulatory environments; limited access to data on local climate, risk, and costs; and mismatches between solutions and the funding available.
Many CA&R solutions are also highly context-specific, making them harder to implement at scale and require longer investment periods. This calls for coordinated action across the spectrum of capital.
“While it’s clear that investing for climate adaption and resilience is still at a nascent stage, the critical work of identifying barriers, assessing commerciality and mapping context-specific investment opportunities is a major step forward that can move investors from exploration to tactical implementation. This analysis helps bring greater transparency to where capital is most needed across Asia, and where investable opportunities may be emerging,” said Mr. Norbert Ling, Head of Fixed Income Portfolio Management, APAC, Invesco
From fragmented responses to coordinated action
Promisingly, funder interest is growing. Among 165 Asia funders surveyed by this study, CA&R ranks as the leading impact theme, with 81 funders (49%) already actively investing and 47 (28%) exploring entry into the space. Collectively, these 165 funders represent over US$1 trillion in Annual Funds Managed (AUM).
Translating interest into capital deployment, however, requires addressing key constraints faced by funders. Pipeline challenges are the top concern for both active or interested funders, as well as inactive funders in this space. Macro-level challenges and deal structuring are also key issues for active or interested funders, while main barriers for inactive funders include limited mandate to invest in the space, alongside knowledge and capacity gaps. Addressing these requires a comprehensive approach that strengthens business models, de-risks projects, and builds capacity and data systems.
Seven key building blocks
Recognising the multifaceted needs of the sector, this report sets out a roadmap for scaling CA&R finance in Asia through seven key actions. These include
- Catalysing action
- Embedding climate adaptation as both a value and growth driver
- Strategic capital mobilisation across the spectrum
- Improving decision-making
- Better climate-risk pricing and valuation of resilience
- Impact-linked decision pathways
- Shared data and knowledge infrastructure
- Laying the foundations
- Climate-aligned financial system
- Cross-sector collaboration and delivery for scale
Further details are set out in the appendix.
For more insights, access the report highlights here. The full report and fund flow dashboard will be available from 19 May.
APPENDIX
7 key building blocks for building lasting CA&R at scale
Catalyse Action
1. CA&R as growth engine and value driver. Investing in CA&R for business operations is not only a defensive strategy but can also unlock new markets and improve competitive advantage. Embedding CA&R into BAU and scaling investable solutions today can help build momentum for broader industry and system transformation.
2. Strategic capital mobilisation across the spectrum. Financing CA&R requires leveraging all forms of capital. Blended and innovative finance can help unlock investment, but only when grounded in strong fundamentals. Successful deployment depends on viable business models, robust data, and execution capacity.
Inform Decisions
3. Climate risk pricing and resilience valuation. Climate risks and resilience benefits, including avoided losses and induced economic, environment, and social impacts, remain systematically undervalued today, distorting investment decisions. Embedding avoided losses and broader impacts into pricing and valuation is key to unlocking capital at scale.
4. Clear impact-linked decision pathways. Clear impact pathways are essential to crowd in capital for CA&R. Given contexts across Asia require that solutions that are highly local and diverse, scaling requires credible causal pathways from action and investment to resilience impact, such as those anchored in a Theory of Change (TOC) and supported by standardised frameworks and comparable indicators rather than uniform metrics.
5. Shared data and knowledge foundations. Closing critical data and capacity gaps is essential to improve risk understanding and decision-making in CA&R. However, data cannot exist in siloes – coordinated investment in localised but interoperable data systems will unlock better pipeline development and capital allocation.
Lay Foundations
6. CA&R aligned-financial systems. Financial services are a foundational enabler of resilience across firms and communities, whether by funding CA&R (e.g., expanding access to capital, financing ecosystem services), or building financial resilience (e.g., by enabling risk transfer and building safety nets that are critical to absorb and manage climate shocks).
7. Cross-sector collaboration and delivery for scale. Lasting CA&R outcomes depend on coordinated action across public, private, and community stakeholders. Stronger collaboration mechanisms, whether among governments, philanthropists, investors, or businesses, can reduce fragmentation and enable faster, more effective capital deployment and action at scale.
Methodology
Insights from the report are based on engagement with ~250 stakeholders, including a survey of 165 funders deploying capital into Asia and 105 interviews. Stakeholders interviewed include commercial and philanthropic funders, financial institutions and insurance companies, corporates, ventures, and ecosystem enablers.
The identification and prioritisation of CA&R solutions for Asia involved narrowing down from 1,400+ recognised global climate adaptation and resilience (CA&R) solutions, aligned with Asia’s climate risks and needs, with maladaptive solutions removed at each stage. Each of the 250+ prioritised solutions were assessed for impact potential and commercial viability, leveraging tracked funding data of ~US$100B over the past five years.
The issuer is solely responsible for the content of this announcement.
About Centre for Impact Investing and Practices
The Centre for Impact Investing and Practices (“CIIP”) is a non-profit centre based in Singapore. Established in 2022 by Temasek Trust, a steward of philanthropic endowments and gifts, the centre’s mission is to foster impact investing and practices in Asia and beyond. CIIP is the anchor partner for the United Nation Development Programme’s Private Finance for the SDGs, providing Asia investors and businesses with clarity, insights and tools that support their contributions towards achieving the SDGs. Temasek and ABC Impact are CIIP’s strategic partners.
About Temasek
Temasek is a global investment company headquartered in Singapore, with a net portfolio value of S$434 billion (US$324b, €299b, £250b, RMB2.35t) as at 31 March 2025. Its Purpose “So Every Generation Prospers” guides it to make a difference for today’s and future generations. Temasek seeks to build a resilient and forward-looking portfolio that will deliver sustainable returns over the long term.
It has 13 offices in 9 countries around the world: Beijing, Hanoi, Mumbai, Shanghai, Shenzhen, and Singapore in Asia; and Brussels, London, Mexico City, New York, Paris, San Francisco, and Washington, DC outside Asia.
About Invesco Ltd.
Invesco Ltd. is one of the world’s leading asset management firms serving clients in more than 120 countries. With US$2.2 trillion in assets under management as of March 31, 2026, we deliver a comprehensive range of investment capabilities across public, private, active, and passive. Our collaborative mindset, breadth of solutions and global scale mean we’re well positioned to help retail and institutional investors rethink challenges and find new possibilities for success. For more information, visit www.invesco.com.
About ImpactSF
The CGIAR Hub for Sustainable Finance (ImpactSF) works to deliver locally relevant evidence & analytics to unlock capital aligned with SDG impacts that enable the food, land and water systems transformation. Hosted by the Alliance of Bioversity & CIAT, ImpactSF builds on CGIAR evidence to deliver data driven solutions that enable financial institutions and investors to de-risk investments through AI-enabled analytics of climate and environmental risks and impacts. As a key technical partner, ImpactSF integrates evidence-based socio-environmental dimensions in all areas of the investment lifecycle, including pipeline development, investment screening & due diligence, investment implementation and post investment monitoring reporting and verification.
Media OutReach
RAM hosts Hong Kong investor briefing as New Zealand’s Active Investor Plus Visa attracts growing global interest
The event comes amid renewed momentum for New Zealand’s Active Investor Plus (AIP) Visa, following changes introduced in April 2025 to simplify the program and attract more international capital into the New Zealand economy. As of 5 May 2026, Immigration New Zealand had received 688 applications under the new settings, representing a potential total minimum investment of $4.015 billion.
The growing demand reflects a broader shift in global wealth movement, as high-net-worth individuals increasingly seek jurisdictions that offer political stability, transparent governance, quality of life and long-term optionality for their families and capital. For many investors, New Zealand’s appeal lies not only in residency access, but also in the opportunity to participate in investments that support business growth, innovation and economic resilience.
Mr Scott Wehl, Founder of RAM Group and Director of RAM New Zealand, said the Hong Kong briefing provided an important forum for partners and investors to better understand the investment and migration opportunities available through the AIP programme.
“New Zealand continues to attract strong interest from global investors seeking stability, transparency and long-term opportunity,” said Mr Wehl.
“Our Hong Kong briefing was designed to help partners and investors better understand the opportunities that the AIP program offers, and how RAM’s income-focused strategies can support both investor objectives and the broader New Zealand economy.”
Supporting New Zealand’s real economy through private credit
A key focus of the briefing was the role private credit can play in supporting New Zealand’s real economy. Private credit can help broaden the country’s business funding ecosystem by providing an additional source of secured, non-bank capital for businesses seeking funding for growth, working capital, expansion or other productive business needs.
The RAM New Zealand Credit Fund is an approved managed fund under the AIP Growth category and may also be included as part of a Balanced category investment portfolio. The Fund is designed to provide investors with consistent income and capital stability through exposure to secured, asset-backed credit investments in New Zealand.
Through this strategy, RAM seeks to direct offshore investor capital into productive domestic investment while maintaining a disciplined focus on risk management, downside protection and portfolio diversification.
“The RAM New Zealand Credit Fund provides an AIP-aligned investment pathway focused on secured, asset-backed New Zealand credit,” said Mr Wehl.
“For investors, the Fund is designed to deliver regular income and capital stability, with liquidity aligned to AIP investment timeframes. For New Zealand, the strategy can support the real economy by directing offshore investor capital into domestic private credit and helping provide secured lending to New Zealand businesses.”
RAM’s credit approach is centred on disciplined credit selection and robust portfolio construction. The firm’s New Zealand credit capability is supported by a highly experienced team with more than 200 years of combined credit market experience, guided by leading credit experts and senior leaders with deep knowledge of New Zealand’s financial markets.
“Our approach is grounded in strong governance, prudent credit assessment and a clear focus on capital preservation, which is particularly important for investors seeking stable, income-focused outcomes across market cycles,” said Mr Wehl.
In addition to the RAM New Zealand Credit Fund, RAM also offers the RAM New Zealand Bond Fund, which may be included as part of a Balanced category investment portfolio. The Fund invests in a portfolio of floating-rate, investment-grade bonds issued by established banks and New Zealand entities, and is designed to prioritise capital stability while generating regular income.
With a long-term commitment to New Zealand, RAM will continue to leverage its international presence, investment capability and experience in income-focused strategies to support global investors and contribute to the continued development and diversification of New Zealand’s capital markets.
Hashtag: #RAM
The issuer is solely responsible for the content of this announcement.
About Real Asset Management
Real Asset Management (RAM) is an alternative asset manager, providing investment solutions in Credit, Real Estate, and Private Equity markets, for institutions and wealthy families globally. RAM was founded in 2010 and has a pan-Asia presence of 7 offices in Auckland, Sydney, Melbourne, Brisbane, Shanghai, Hong Kong and Manila.
RAM provides more than 25 investment strategies and has a team of over 230 finance professionals managing over NZ$9.8bn in assets. RAM is registered as a financial services provider in New Zealand (FSP1011247). We also provide a global set of investment solutions through our group companies licensed by the Australian Securities and Investments Commission (AFSL 484263), and the Securities & Futures Commission of Hong Kong (CE BGL803).
For more information about RAM New Zealand, please visit 
https://ramgroup.co.nz/
Media OutReach
Amplexd Therapeutics Initiates Phase 2 Clinical Trial of Investigational EGCg-Based HPV Therapy
High-risk HPV is the primary driver of cervical cancer, which remains a significant public health burden, particularly across the Asia-Pacific region. High-risk HPV prevalence amongst Chinese women is estimated at 12.8%[1] with China representing 23% of cervical cancer cases globally[2].
The randomized, placebo-controlled Phase 2 study is being conducted at The Chinese University of Hong Kong in collaboration with Prince of Wales Hospital, with recruitment currently underway. The study will evaluate the safety and efficacy of Amplexd’s investigational therapy in women diagnosed with ASC-US and low-grade squamous intraepithelial lesions (LSIL) alongside confirmed hr-HPV infection. Clinical data are expected in Q1 2027.
Amplexd’s investigational therapy is a proprietary, shelf-stable vaginal suppository formulation containing epigallocatechin gallate (EGCg), a bioactive compound derived from green tea, designed for localized self-administration at the site of disease.
“Currently, there is a significant unmet medical need for localized, non-surgical therapies specifically indicated for low-grade lesions associated with high-risk HPV. The standard of care is largely limited to increased surveillance and ‘watchful waiting,’ which can impose both psychosocial and financial burdens on patients,” said Alia Rahman, Chief Executive Officer of Amplexd. “Moreover, in many resource-constrained settings including large swaths of Asia-Pacific, access to surgical intervention and specialized follow-up care is limited. Previously published, peer-reviewed clinical and preclinical studies have explored the use of EGCg-based topical formulations in the treatment of HPV and cervical lesions. Building on this body of research, we developed a shelf-stable formulation designed for self-administration and early therapeutic intervention.”
The Phase 2 trial will evaluate endpoints including lesion regression, viral clearance, and overall safety profile, with the goal of generating data on the potential for early therapeutic intervention in hr-HPV-associated disease.
Additional information about the study can be found at www.drugoffice.gov.hk under trial identifier eCTS-2026-021 and at www.clinicaltrials.gov under trial identifier NCT07572396.
Important Information
This clinical trial has been authorized by the Hong Kong Department of Health. Participation will be subject to eligibility criteria and informed consent. This investigational therapy has not been approved by the U.S. Food and Drug Administration, and its safety and efficacy have not been established.
This press release contains forward-looking statements regarding clinical development plans and potential benefits of the investigational therapy. These statements involve risks and uncertainties that could cause actual results to differ materially. Amplexd Therapeutics, Inc. undertakes no obligation to update these statements except as required by law.
Cervical Cancer Incidence and Mortality Trends in China: The Role of Screening,
Cancer Letters, Volume 642 (2026) 218286, ISSN 0304-3835. https://doi.org/10.1016/j.canlet.2026.218286.
Hashtag: #AmplexdTherapeutics #hrHPV #HPVtherapy #HPV #cervicaldysplasia #LSIL #ASCUS #Phase2clinicaltrial #womenshealth #EGCg #cervicalcancer #investigationaltherapy #clinicaltrial
The issuer is solely responsible for the content of this announcement.
About Amplexd Therapeutics, Inc.
Amplexd Therapeutics, Inc. is a biotechnology company pioneering science-driven therapies for women’s health and related diseases with high unmet need. Its pipeline leverages novel mechanisms and accessible delivery modalities to expand treatment options for patients.
Media OutReach
The 2026 VinFuture Prize Receives More Than 1,800 Nominations as Its Global Nomination Network Expands Fourteenfold After Six Years
At the close of the nomination period for the 2026 season, the VinFuture Prize, a global science and technology prize recorded 1,819 nominations from around the world, supported by a network of more than 17,000 nominators spanning 117 countries and territories.
HANOI, VIETNAM – Media OutReach Newswire – 18 May 2026 – After six seasons, the VinFuture Prize has not only expanded its influence in the international scientific community, but has also affirmed its position as a prestigious global prize dedicated to identifying and honoring breakthroughs with profound significance for the future of humanity.
A Global Network Bringing Together More Than 17,000 Outstanding Minds
This year’s VinFuture nominations span a wide range of critical fields, including medicine and healthcare (38.4%), environmental and earth sciences (17%), energy, transportation, and construction (15%), food and agriculture (10.6%), as well as other scientific and technological disciplines (19%).
At the same time, the official nominator network of the VinFuture Prize has continued to expand substantially, reaching 17,154 nominators from 117 countries and territories across all five continents. This represents an increase of approximately 16% compared with the 2025 season and a more than fourteenfold expansion compared with the inaugural season in 2021. Moreover, the number of countries and territories represented within the nominator network has nearly doubled over the past six years.
Notably, 1,415 nominators for the 2026 VinFuture Prize are ranked among the world’s top 2% most-cited researchers. Nearly 8,000 experts are affiliated with leading universities, research institutes, and scientific organizations worldwide, including Australian Academy of Science, Massachusetts Institute of Technology (United States), Stanford University (United States), Harvard University (United States), University of California, Berkeley (United States), University of Oxford (United Kingdom), National University of Singapore (Singapore), Nanyang Technological University (Singapore), and Weizmann Institute of Science (Israel), among others.
Participating on a voluntary basis, these nominators play a vital role in identifying and recommending outstanding scientific innovations capable of generating meaningful and lasting improvements to the lives of billions of people worldwide. They also contribute significantly to extending the global reach of the VinFuture Prize within the international scientific community and promoting cross-border academic connections. Several distinguished nominators have traveled to Vietnam during the 2024 and 2025 VinFuture Sci-Tech Weeks to connect and exchange knowledge directly with the Vietnamese scientific community.
“The continued growth in both the number of nominations and our network of more than 17,000 nominators reflects the increasing confidence that leading scientists and prestigious institutions around the world place in VinFuture Prize and its mission to identify and honor scientific and technological innovations with meaningful impact on humanity. This momentum also reinforces our commitment to upholding rigorous and transparent evaluation standards, while advancing a long-term vision of connecting global intellect in pursuit of a better future for all,” said Dr. Thai-Ha Le, Managing Director of the VinFuture Foundation.
Following the conclusion of the nomination period, the Pre-Screening Committee will begin the process of evaluating and selecting the most outstanding scientific works for consideration by the VinFuture Prize Council in the final judging round, which is expected to continue through early September 2026. All nominations will undergo a rigorous multi-layer evaluation process based on stringent international standards to ensure the highest levels of scientific integrity, fairness, and transparency.
The core evaluation criteria include the degree of scientific and technological advancement, the potential for meaningful impact on human life, as well as the scale and long-term sustainability of the proposed innovations.
Vietnam’s Growing Imprint on the Global Innovation Map
After six seasons, the VinFuture Prize has firmly established its reputation and standing within the global science and technology landscape. Several VinFuture Laureates have subsequently been honored by some of the world’s most prestigious scientific awards, including the Nobel Prize, the Queen Elizabeth Prize for Engineering, and the Breakthrough Prize, demonstrating VinFuture’s ability to recognize, at an early stage, innovations with foundational significance for the future of humanity.
Notable examples include Prof. Omar Yaghi (2021 VinFuture Special Prize; 2025 Nobel Prize in Chemistry); Dr. Katalin Karikó and Prof. Drew Weissman (2021 VinFuture Grand Prize; 2023 Nobel Prize in Physiology or Medicine); Drs. Demis Hassabis and John Jumper (2022 VinFuture Special Prize; 2024 Nobel Prize in Chemistry); Prof. Geoffrey Hinton (2024 VinFuture Grand Prize; 2024 Nobel Prize in Physics); as well as Prof. Yoshua Bengio, Prof. Yann LeCun, Prof. Geoffrey Hinton, Mr. Jensen Huang, and Prof. Fei-Fei Li (2024 VinFuture Grand Prize; 2025 Queen Elizabeth Prize for Engineering). Additional examples include Prof. Daniel Drucker, Prof. Joel Habener, Prof. Jens Juul Holst, and Assoc. Prof. Svetlana Mojsov (2023 VinFuture Special Prize), who later received the 2025 Breakthrough Prize.
Beyond recognizing transformative scientific achievements, VinFuture has become a point of convergence for knowledge, collaboration, and the aspiration to serve humanity. Over the course of six seasons, VinFuture has contributed to shaping a more open, connected, and inspiring scientific ecosystem, while positioning Vietnam as an increasingly important destination on the global innovation map.
Hashtag: #VinFuture
The issuer is solely responsible for the content of this announcement.
-
Feature/OPED6 years agoDavos was Different this year
-
Travel/Tourism10 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz3 years agoEstranged Lover Releases Videos of Empress Njamah Bathing
-
Banking8 years agoSort Codes of GTBank Branches in Nigeria
-
Economy3 years agoSubsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking3 years agoSort Codes of UBA Branches in Nigeria
-
Banking3 years agoFirst Bank Announces Planned Downtime
-
Sports3 years agoHighest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn